This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday

Apogee Therapeutics, Inc.
Arcturus Therapeutics
Carnival Corporation
Tandem Diabetes Care, Inc.
Union Pacific Corporation

Apogee Therapeutics, Inc.

APGE

0.00

Arcturus Therapeutics

ARCT

0.00

Carnival Corporation

CCL

0.00

Tandem Diabetes Care, Inc.

TNDM

0.00

Union Pacific Corporation

UNP

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Jamie Rollo upgraded Carnival Corp (NYSE:CCL) from Equal-Weight to Overweight and cut the price target from $33 to $31. Carnival shares closed at $24.16 on Wednesday. See how other analysts view this stock.
  • Truist Securities analyst Richard Newitter upgraded Tandem Diabetes Care Inc (NASDAQ:TNDM) from Hold to Buy and raised the price target from $27 to $35. Tandem Diabetes Care shares closed at $23.85 on Wednesday. See how other analysts view this stock.
  • Evercore ISI Group analyst Jonathan Chappell upgraded Union Pacific Corp (NYSE:UNP) from In-Line to Outperform and raised the price target from $260 to $262. Union Pacific shares closed at $236.57 on Wednesday. See how other analysts view this stock.

Considering buying UNP stock? Here’s what analysts think:

Photo via Shutterstock